Soleno Therapeutics Inc
Biotechnology · Healthcare
Patricia Hirano
Equibles does not estimate personal net worth.
About Patricia Hirano
Soleno Therapeutics Inc reported in an 8-K filed May 18, 2026 that Patricia Hirano resigned as Senior Vice President, Regulatory Affairs, effective May 18, 2026. The proxy statement of Soleno Therapeutics Inc reports total compensation of $6,051,410 for Patricia Hirano in fiscal 2024, including a base salary of $375,000. Disclosed compensation is on record for 6 fiscal years.
“each of Anish Bhatnagar, M.D. (Chief Executive Officer), Jennifer Fulk (Chief Financial Officer), Patricia Hirano (Senior Vice President, Regulatory Affairs), Kristen Yen (Senior Vice President, Global Clinical Operations & Patient Advocacy), Meredith Manning (Chief Commercial Officer), Manher (AJ) Joshi (Chief Development Officer), Kevin Norrett (Chief Business Officer) and Michael Huang (Senior Vice President, Clinical Development) resigned from his or her positions as an officer of the Company, in each case, effective as of the Effective Time.”
Affiliation history
-
Soleno Therapeutics Inc
Proxy statement
Start not stated–2026-05-18
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Soleno Therapeutics Inc | Senior Vice President, Regulatory Affairs | $375,000 | $6,051,410 |
| 2023 | Soleno Therapeutics Inc | Senior Vice President, Regulatory Affairs | $340,000 | $1,028,973 |
| 2022 | Soleno Therapeutics Inc | Senior Vice President, Regulatory Affairs | $326,000 | $476,934 |
| 2021 | Soleno Therapeutics Inc | Vice President, Regulatory Affairs | $315,000 | $920,826 |
| 2020 | Soleno Therapeutics Inc | Vice President, Regulatory Affairs | $300,000 | $891,950 |
| 2019 | Soleno Therapeutics Inc | Vice President, Regulatory Affairs | $260,208 | $355,946 |